I schemic stroke results from vascular occlusion that reduces the cerebral blood flow perfusing an area of the brain. Intravenous tissue plasminogen activator (IVtPA) administered within 4.5 hours after symptom onset in acute ischemia significantly increases the percentage of patients with a modified Rankin Scale (mRS) score of 0 or 1 after 3 months. 1 Earlier treatment and prompt recanalization are clearly associated with improved mortality and clinical outcome because of the prevention of neuronal ischemia. 2 Repeated IVtPA is contraindicated in patients with a history of stroke in the previous 3 months because of a greater risk of intracranial hemorrhage for brain-blood barrier disruption in the previously infarcted area. 3 The cumulative risk of stroke recurrence in the 5 years following the initial stroke is 19% to 32%, 4 and approximately half of stroke recurrences occur within days or weeks from the occurred ischemic stroke. 5 For this reason, repeating IVtPA in following strokes has been a muchdebated issue in the past decades. Recent studies reported that intravenous thrombolysis (IVT) is safe and efficient even in patients with early recurrent stroke (ERS) (< 3 mo). 6,7 Timo Kahles et al 8 reported that repeated IVtPA in 19 subjects with ERS that occurred within 90 days (median, 30 d; range, 13 to 50 d) from the previous stroke was safe and effective. Favorable clinical [mRS score and 24-h National Institute of Health Stroke Scale (NIHSS)] and radiologic (small infarct volume and high recanalization rates) outcomes after the first IVT have supported the decision to perform the second thrombolysis. Moreover, a recent study highlighted the importance of neuroimaging in reperfusion selection. 9, 10 This article describes the case of a patient with ERS within 10 days from the previous stroke who underwent repeated IVT treatment after neuroradiologic evaluation without related complications.
CASE PRESENTATION
A healthy, Caucasian 59-year-old man was admitted to our Stroke Unit (University Hospital of Trieste) for a sudden onset of right severe hypoesthesia and ipsilateral mild hemiparesis, NIHSS of 4. No other focal deficits were identified. The patient had no medical history of cerebrovascular or cardiovascular risk factors. Brain computed tomography (CT) scan showed no abnormalities with the Alberta Stroke program, early CT score (ASPECT) of 10. Angio-CT of epiaortic and intracranial vessels highlighted an occlusion of the left extracranial internal carotid artery. The patient was treated with IVtPA after 165 minutes after the acute stroke onset without side effects. Neurological deficit was rapidly improved to a 24-hour NIHSS of 0. CT scan after 24 hours showed a small and nuanced hypodensity in the left frontal lobe. A specific diagnostic work-up (laboratory test, including autoimmune and thrombolytic pattern, electrocardiogram, transesophageal echocardiogram, prolonged telemetric monitoring) was performed, and no major causes for ischemic stroke were found. Ultrasound of epiaortic vessels confirmed the vessel occlusion. After 7 days, the patient was discharged with NIHSS of 0 and mRS score of 0 and was prescribed an antiplatelet therapy. Two days after the discharge, the patient was newly admitted to our Stroke Unit for a sudden onset of right hemiparesis, hypoesthesia, hemianopia, facial palsy, and aphasia, NIHSS of 17. Brain CT scan showed a more evident hypodensity (lesion hypodensity: 19.01 HU; corresponding contralateral zone: 28 HU) in the area of the previous lesion (volume of 4 cm 3 ) with no other acute radiologic findings (ASPECT 10). Angio-CT confirmed the known left internal carotid occlusion and showed an occlusion of the left-middle cerebral artery tract M2. Perfusion CT scan showed a small deep core and a large penumbra (22 and 247 cm 3 , respectively) in the M2 territory. The patient underwent IVtPA after 130 minutes after stroke onset without adverse effects. Mechanical treatment was not performed because of the highly distal thrombosis. At 24 hours, NIHSS was 7, and CT scan showed an acute ischemic lesion in the left basal ganglia area and in the frontal lobe (corresponding to the core zone) without hemorrhagic transformation. During hospitalization, prolonged cardiac monitoring showed atrial fibrillation. After a week, oral anticoagulants were started. The patient was discharged with Broca aphasia and mild motor deficit of the right arm (NIHSS of 5; mRS = 1). Figure 1 describes the radiologic findings showing lesions of the first and the second ischemic stroke.
DISCUSSION AND CONCLUSION
This case report suggests that further randomized studies may evaluate whether repeated IVtPA may be safe and effective in ERS occurring shortly after a previous stroke when patients show favorable clinical and radiologic findings.
FIGURE 1.
A 59-year-old man presented with early recurrent stroke characterized by sudden onset of right hemiparesis, hypoesthesia, hemianopia, facial palsy, and aphasia, National Institute of Health Stroke Scale (NIHSS) 17. A, computed tomography (CT) scan shows a small hypodensity (19.01 HU; volume 4 cm 3 ) caused by the first ischemic stroke. B, CTP core-penumbra color map with estimated core and penumbra areas, highlighted in red and green, respectively. CTP shows a small deep core and a large penumbra (22 and 247 cm 3 , respectively) in the M2 territory. CBF map (C), CBV map (D), MTT map (E). The patient was treated again with thrombolysis and discharged with Broca aphasia and mild motor deficit in the right arm (NIHSS 5; modified Rankin Scale = 1). Control CT scan was performed after 2 weeks and showed an acute ischemic lesion in the left basal ganglia area and in the frontal lobe (F). CBF indicates cerebral blood flow; CBV, cerebral blood volume; CTP, CT perfusion; MTT, mean transit time.
In our case study, the decision to opt for a repeated IVtPA has been motivated by a period of complete neurological regression (NIHSS 0), minor disability (mRS score of ≤ 2), and small infarct volume after the previous stroke. Therefore, small volume core and wide volume penumbra at perfusion CT supported the decision of IVtPA repetition. The decision of treating patients with ERS is one of the most debated issues in modern stroke clinical care. In myocardial infarction and pulmonary embolism, repeated thrombolysis has been shown to be safe and effective. 11, 12 Less evidence is available for acute ischemic stroke. Together with other contraindications, the repeated administration of IVT in ERS is contraindicated within 3 months from the first stroke because of the high risk of cerebral bleeding and potential anaphylactic reactions. 13, 14 Repeated IVtPA may increase the risk of intracranial hemorrhage because of the disruption of the brain-blood barrier caused by the previous ischemic stroke. 15, 16 ERS incidence varies in literature: the cumulative risk of stroke recurrence within 5 years after initial stroke is 19% to 32%, 4 and half of stroke recurrences occur within days or weeks from the ischemic stroke. 5 Therefore, considering clinical and radiologic features to support decision-making in thrombolysis therapy in patients with ERS is paramount, particularly within 15 days from the first ischemic event. Several small-scale case reports and case studies reported on ERS patients who underwent repeated thrombolysis. The treatment was usually repeated within 3 months; only in 1 case report was IVT repeated within the first 15 days from the previous stroke. [17] [18] [19] In a series of 19 ERS patients who underwent repeated IVT treatment, Timo Kahles et al 8 reported that thrombolysis was safe and effective, but functional independence was less frequent after the second thrombolysis than after the first stroke. When selecting patients, the clinical outcome from the first stroke (NIHSS and mRS) and radiologic severity of the first ischemic injury must be taken into account. Repeated IVT may be considered for patients with small infarct volumes and optimal improvement. 20 Our patient had NIHSS and mRS of 0 at second ischemic event onset, in line with the Timo Kahles and colleagues study results whose patients had a median NIHSS of 1 (0 to 3), and 79% of patients' mRS was ≤ 2. Our patient's brain CT scan showed small infarct volume (4 cm 3 ), similar to the Timo Kahles and colleagues study data that reported a median volume of 1.5 cm 3 (0.5 to 3.1 cm 3 ). CT-HU may be useful to evaluate the evolution of the ischemic lesion over time. Govind and Sukumar 21 stated that acute infarct HU value is higher than 19.13, subacute infarct HU ranges from 9.55 to 19.13, and, for chronic infarct, it is lower than 9.55. In our case report, the lesion hypodensity of the first ischemic event was 19.01 HU, demonstrating a subacute infarct. Therefore, a low HU value of the previous stroke may be a sign of lesion stabilization. Several studies have shown that lesion core volume greater than 70 mL on multimodal techniques is a contraindication to endovascular treatment. 22 Our patient's CT perfusion showed a core of 22 cm 3 . Our report suggests further research to evaluate whether patients with small infarct volumes, low CT-HU, small CT perfusion core with large penumbra, and robust improvement (NIHSS and mRS) may be considered for repeated IVT within 15 days. Future studies may also identify other selection criteria for safe use of repeated IVT in ERS.
